Daily Statistics
As of05/23/23 NAME | 30-DAY SEC YIELD (WITHOUT WAIVER) | 30-DAY SEC YIELD (WITH WAIVER) | 30-DAY MEDIAN BID/ASK SPREAD | PREVIOUS DAY VOLUME | 20-DAY AVG VOLUME | PREMIUM/ DISCOUNT | YTD Total Return (NAV) |
---|---|---|---|---|---|---|---|
BNY Mellon Innovators ETF | - | - | - | 1,205 | 0 | -0.00% | - |
Past performance is no guarantee of future results.
30-Day SEC Yield - 30-Day SEC Yield is based upon dividends per share from net investment income during the past 30 days, divided by the period ended maximum offering price per share and annualized. Unsubsidized yield displays what the fund's 30-Day SEC Yield would have been had no fee waiver or expense reimbursement been in place during the period.
30-Day Median Bid-Ask Spread - Gives investors the midpoint within the spread between an ETF’s selling price and buying price. It is calculated over the last 30 days in 10 second intervals by dividing the difference between the bid (sell price) and offer (buy price) by the midpoint of the National Best Bid Offer (NBBO) and identifying the median of those values.
20-Day Avg Volume - 20-Day Average Volume is the sum of last 20 days of trading volume divided by 20 days.
Premium / Discount - The amount the fund is trading above or below the reported NAV expressed as a percentage of the NAV. When the fund's market price is greater than the fund's NAV, it is said to be trading at a "Premium" and the percentage is expressed as a positive number. When the fund's market price is less than the fund's NAV, it is said to be trading at a "Discount" and the percentage is expressed as a negative number.
Historical NAV and Market Price
Historical Premium/Discount
Prospectus Fee Table Expense Ratios
Fees as stated in the prospectus Fee Description | Total Expense Ratio (%) |
---|---|
Management Fee | 0.50% |
Other Expenses | 0.00% |
Total Expenses | 0.50% |
The Total Expenses is the actual fund expense ratio applicable to investors.
Portfolio Manager/Sub-Investment Adviser
The fund's investment adviser is BNY Mellon ETF Investment Adviser, LLC (Adviser) and the fund's sub-adviser is Newton Investment Management North America LLC (NIMNA), an affiliate of the Adviser.
John Porter and Edward Walter are the fund's primary portfolio managers, positions they have held since the fund's inception in May 2023. Mr. Porter is Chief Investment Officer and Head of Equity at NIMNA. Mr. Walter is a portfolio manager and member of NIMNA's research team. Each portfolio manager is jointly and primarily responsible for the day-to-day management of the fund's portfolio.
Top Holdings
Download Total Holdings
As of 05/24/23
Holdings | % PortfolioWeight |
---|---|
NVIDIA CORP | 4.99 |
ALPHABET INC-CL C | 4.97 |
ILLUMINA INC | 3.04 |
COSTAR GROUP INC | 3.04 |
TWILIO INC - A | 3.02 |
SNOWFLAKE INC-CLASS A | 2.96 |
NETFLIX INC | 2.57 |
ARES MANAGEMENT CORP - A | 2.50 |
BIOMARIN PHARMACEUTICAL I | 2.44 |
CACTUS INC - A | 2.42 |
DEXCOM INC | 2.39 |
ALIGN TECHNOLOGY INC | 2.38 |
LULULEMON ATHLETICA INC | 2.33 |
REPLIGEN CORP | 2.18 |
BLOCK INC | 2.09 |
FRESHPET INC | 2.06 |
DYNATRACE INC | 2.04 |
ALBEMARLE CORP | 2.04 |
INSMED INC | 2.02 |
PELOTON INTERACTIVE INC-A | 1.99 |
TRADE DESK INC/THE -CLASS | 1.98 |
INSPIRE MEDICAL SYSTEMS I | 1.97 |
ASCENDIS PHARMA A/S - ADR | 1.95 |
ALNYLAM PHARMACEUTICALS I | 1.95 |
SAREPTA THERAPEUTICS INC | 1.94 |
INTUITIVE SURGICAL INC | 1.92 |
SHOPIFY INC - CLASS A | 1.88 |
LIBERTY MEDIA CORP-LIBERT | 1.86 |
DREYFUS INSTITUTIONAL PRE | 1.81 |
DOUBLEVERIFY HOLDINGS INC | 1.62 |
DENALI THERAPEUTICS INC | 1.58 |
CYTOKINETICS INC | 1.52 |
10X GENOMICS INC-CLASS A | 1.49 |
XENON PHARMACEUTICALS INC | 1.49 |
OUTSET MEDICAL INC | 1.48 |
PRIVIA HEALTH GROUP INC | 1.47 |
IRHYTHM TECHNOLOGIES INC | 1.47 |
PACIFIC BIOSCIENCES OF CA | 1.45 |
AIRBNB INC-CLASS A | 1.44 |
MONGODB INC | 1.42 |
AZEK CO INC/THE | 1.40 |
TRANSMEDICS GROUP INC | 1.39 |
PROTHENA CORP PLC | 1.37 |
FARFETCH LTD-CLASS A | 1.28 |
TWIST BIOSCIENCE CORP | 1.13 |
KEROS THERAPEUTICS INC | 1.07 |
DRAFTKINGS INC-CL A | 1.04 |
VITAL FARMS INC | 1.00 |
GARMIN LTD | 0.99 |
CRINETICS PHARMACEUTICALS | 0.99 |
CHEWY INC - CLASS A | 0.92 |
Net Current Assets | 0.26 |
% Portfolio Weight is calculated using the closing market price of each security from the prior business day.
Holdings are subject to change. The holdings listed should not be considered recommendations to buy or sell a security.
Main Risks
ETFs trade like stocks, are subject to investment risk, including possible loss of principal.
Equities are subject to market, market sector, market liquidity, issuer, and investment style risks, among other factors, to varying degrees. There can be no assurance that a company identified as an innovation-driven company by NIMNA will ultimately introduce a new product or service or that such product or service may not be significantly delayed or have the affect NIMNA anticipated. The returns on a portfolio of securities that are viewed by NIMNA as innovation-driven companies may trail the returns of a portfolio that is not limited to securities of innovation-driven companies. Investing only in securities of innovation-driven companies may affect the fund’s exposure to certain types of investments and may adversely impact the fund’s performance depending on whether such investments are in or out of favor in the market. The fund may significantly overweight or underweight certain companies, industries or market sectors, which may cause the fund's performance to be more or less sensitive to developments affecting those companies, industries or sectors.
The fund is non-diversified, which means that the fund may invest a relatively high percentage of its assets in a limited number of issuers. Therefore, the fund's performance may be more vulnerable to changes in the market value of a single issuer or group of issuers and more susceptible to risks associated with a single economic, political or regulatory occurrence than a diversified fund.
Although fund shares are listed for trading on an exchange and may be listed or traded on other U.S. and non-U.S. stock exchanges as well, there can be no assurance that an active trading market for such fund shares will develop or be maintained. Trading in fund shares may be halted due to market conditions or for reasons that, in the view of the listing exchange, make trading in fund shares inadvisable. In addition, trading in fund shares on an exchange is subject to trading halts caused by extraordinary market volatility pursuant to exchange "circuit breaker" rules. There can be no assurance that the requirements of the listing exchange necessary to maintain the listing of the fund will continue to be met or will remain unchanged or that fund shares will trade with any volume, or at all, on any stock exchange.
Please refer to the prospectus for a more complete discussion of the fund's main risks.
Literature
PRODUCT INFORMATION
- Download
- Share
- Subscribe
- Order
BNY Mellon Thematic ETF Presentation | Download | ||
BNY Mellon ETF Profile Sheet | Download |
Prospectus and Reports
- Download
- Share
- Subscribe
- Order
Prospectus | Download | ||
Summary Prospectus | Download | ||
SAI | Download |
Investors should consider the investment objectives, risks, charges, and expenses of the fund carefully before investing. Download a prospectus, or summary prospectus, if available, that contains that and other information about the fund, and read it carefully before investing.
ETF shares are listed on an exchange, and shares are generally purchased and sold in the secondary market at market price. At times, the market price may be a premium or discount to the ETF's per share NAV. In addition, ETFs are subject to the risk that an active trading market for an ETF's shares may not develop or be maintained. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions. Any applicable brokerage commissions will reduce returns.
ETFs trade like stocks, are subject to investment risk, including possible loss of principal. Equities are subject to market, market sector, market liquidity, issuer, and investment style risks, among other factors, to varying degrees. The risks of investing in this ETF typically reflect the risks associated with the types of instruments in which the ETF invests. Diversification cannot assure a profit or protect against loss.
The fund will issue (or redeem) fund shares to certain institutional investors known as “Authorized Participants” (typically market makers or other broker-dealers) only in large blocks of fund shares known as “Creation Units.” BNY Mellon Securities Corporation (“BNYMSC”), a subsidiary of the BNY Mellon, serves as distributor of the fund. BNYMSC does not distribute fund shares in less than Creation Units, nor does it maintain a secondary market in fund shares. BNYMSC may enter into selected agreements with Authorized Participants for the sale of Creation Units of Creation Units of fund shares.
Index returns are for illustrative purposes only. Index performance returns do not reflect any management fees, transaction costs or expenses. Indexes are unmanaged and one cannot invest directly in an index. Past performance does not guarantee future results.
This material has been distributed for informational purposes only and should not be considered as investment advice or a recommendation of any particular investment, strategy, investment manager or account arrangement and should not serve as a primary basis for investment decisions.
Please consult a legal, tax or investment professional in order to determine whether an investment product or service is appropriate for a particular situation.